The Effect of Chronic Trimetazidine Administration on Left Ventricular Function and Quality Of Life in Libyan Patients with Heart Failure
Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2017, Vol 1, Issue 1
Abstract
Background: Heart failure is a major cardiovascular disease and public health problem. It is complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of the blood. Trimetazidine is a cardio-protective drug that exerts cytoprotective effects by inhibition of the mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Aim: This study was aimed to examine effects of chronic trimetazidine administration on left ventricular function, symptoms and quality of life of patients with heart failure (secondary to ischemic or non-ischemic heart disease). Methods: This study was conducted at Cardiology unit of Tripoli Medical Center on 46 Libyan patients (39 - 85 years, 27 men : 19 women) diagnosed with chronic heart failure due to ischemic or non-ischemic heart diseases. The patients received, in addition to the standard therapy of heart failure, 35 mg of trimetazidine twice per day for six months. Patients were evaluated for left ventricular function by echocardiography after six months of the therapy. Symptoms and quality of life were assessed by Minnesota questionnaire after six months of trimetazidine use. Results: The mean of left ventricular ejection fraction before treatment with trimetazidine was 37.9% and after treatment was 40.6%. The mean of left ventricular end diastolic diameter before treatment with trimetazidine was 63.544 mm and after treatment was 62.261 mm. Trimetazidine therapy was associated with a considerable improvement in left ventricular ejection fraction (p < 0.05) and a significant decrease in left ventricular end diastolic diameter (p < 0.05). There was no improvement in symptoms and quality of life of heart failure patients on trimetazidine therapy. Conclusion: Treatment with trimetazidine for six months with the conventional heart failure drugs improves the left ventricular function.
Authors and Affiliations
Narges A Albibas, Osama A Bheleel, Fathi M Sherif
Keywords
Related Articles
- EP ID EP567408
- DOI 10.26717/BJSTR.2017.01.000135
- Views 176
- Downloads 0
Biomarkers for Early Detection of Hypertensive Disorders in Pregnancy: Current Applications and Future Directions- The Role of Extracellular Matrix
Hypertensive disorders in pregnancy (HDP) are the most common medical complications, affecting 5–10% of pregnancies worldwide. Their early detection is critical for risk stratification and prevention of further pregnancy...
Pd-1/Pd-L Pathway: Its Preclinical Rationale and Clinical Application in Lymphoid Neoplasms
The PD-1/PD-L1 pathway plays an important role in mediating immune tolerance in physiological stateand is an important mechanism by which malignancies can evade the host immune response. PD-1 inhibitors may be particular...
A Vaccine for Syphilis
Design and application of a vaccine for syphilis is proposed. Syphilis, once a widespread and crippling disease, has decreased in prevalence and significance due to public health education and the use of penicillin, whic...
A Form of Decision –Making Failure in Arabian Nursing Education
Late in the twentieth century and, exactly, in 1983, Yarmouk University/ Jordan started its Bachelor of nursing programme. At that time, when the Faculty of Nursing (FoN) had no nursing PhD holders, other than the Dean,...
Combining X-Rays and Neutrons to Shed Light in the Conformational Changes in Aminoacids
Amino acids are small organic molecules having both amino and carboxylic acid groups bound to the a-carbon, with a general formula NH2- CH(R)-COOH. Their side chains, R, can vary - saml our bulky, hidrophobic our hydroph...